Spinal Tumours in Dogs: Welfare-Centred Diagnosis and Treatment

Spinal tumours cause significant pain and progressive neurological deficit in affected dogs. Early diagnosis and welfare-centred treatment planning improves quality of life.

Key Facts

Spinal tumours account for approximately 2-3% of all canine cancers
Primary tumours include meningiomas, nerve sheath tumours, and astrocytomas
Secondary (metastatic) tumours from prostate, mammary, and lung cancers are more common than primary spinal neoplasia
MRI is the gold-standard diagnostic tool for spinal tumour characterisation

Welfare Considerations

Spinal tumour pain is severe and progressive — affected dogs experience allodynia (pain from non-painful stimuli) and hyperalgesia alongside neurological deficits. Welfare assessment requires distinguishing pain from neurological dysfunction in treatment planning. Surgical decompression, radiation therapy, and palliative pain management are the main options. Quality of life scoring using validated tools helps guide decisions about treatment intensity versus comfort-focused care.

What You Can Do

Seek specialist neurology or oncology referral for dogs with progressive spinal signs
Ensure comprehensive pain management regardless of whether curative treatment is pursued
Use validated quality-of-life tools such as the HHHHHMM scale to guide treatment decisions
Discuss prognosis honestly with your veterinary team to make informed welfare-centred choices